Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / Common Stock, $0.0001 par value
-
Shares outstanding
-
39,817,308
-
Number of holders
-
19
-
Total 13F shares, excl. options
-
660,884
-
Shares change
-
-142,278
-
Total reported value, excl. options
-
$1,502,744
-
Value change
-
-$141,291
-
Number of buys
-
9
-
Number of sells
-
11
-
Price
-
$2.20
Institutional Holders of MAIA Biotechnology, Inc. - Common Stock, $0.0001 par value (MAIA) as of Q1 2024
As of 31 Mar 2024 MAIA Biotechnology, Inc. - Common Stock, $0.0001 par value (MAIA) had 19 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 660,884 shares of stock of the company.
Largest 10 holders included VANGUARD GROUP INC, Centric Wealth Management, GEODE CAPITAL MANAGEMENT, LLC, BRIDGEWAY CAPITAL MANAGEMENT, LLC, Virtu Financial LLC, JANE STREET GROUP, LLC, CITADEL ADVISORS LLC, Naviter Wealth, LLC, STATE STREET CORP, and NORTHERN TRUST CORP.
This table shows 19 institutional shareholders of the security as of 31 Mar 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.